<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p18" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_18{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_18{left:341px;bottom:30px;}
#t3_18{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_18{left:377px;bottom:30px;}
#t5_18{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_18{left:540px;bottom:30px;}
#t7_18{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_18{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_18{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_18{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_18{left:285px;bottom:827px;letter-spacing:-0.25px;}
#tc_18{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_18{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_18{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_18{left:1109px;bottom:28px;letter-spacing:0.23px;}
#tg_18{left:36px;bottom:200px;}
#th_18{left:46px;bottom:194px;letter-spacing:0.13px;}
#ti_18{left:260px;bottom:194px;}
#tj_18{left:36px;bottom:183px;}
#tk_18{left:42px;bottom:177px;letter-spacing:0.11px;word-spacing:0.01px;}
#tl_18{left:45px;bottom:160px;letter-spacing:0.12px;}
#tm_18{left:45px;bottom:143px;letter-spacing:0.13px;}
#tn_18{left:36px;bottom:133px;}
#to_18{left:46px;bottom:127px;letter-spacing:0.13px;word-spacing:-0.06px;}
#tp_18{left:332px;bottom:127px;}
#tq_18{left:36px;bottom:116px;}
#tr_18{left:46px;bottom:110px;letter-spacing:0.12px;word-spacing:-0.03px;}
#ts_18{left:556px;bottom:110px;}
#tt_18{left:36px;bottom:748px;letter-spacing:0.48px;}
#tu_18{left:36px;bottom:729px;letter-spacing:0.25px;}
#tv_18{left:152px;bottom:748px;letter-spacing:0.32px;word-spacing:-0.31px;}
#tw_18{left:896px;bottom:745px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tx_18{left:36px;bottom:488px;letter-spacing:-0.1px;}
#ty_18{left:36px;bottom:470px;letter-spacing:-0.27px;}
#tz_18{left:184px;bottom:702px;letter-spacing:-0.1px;}
#t10_18{left:184px;bottom:684px;letter-spacing:-0.09px;}
#t11_18{left:184px;bottom:666px;letter-spacing:-0.1px;}
#t12_18{left:272px;bottom:673px;letter-spacing:-0.13px;}
#t13_18{left:184px;bottom:282px;letter-spacing:-0.1px;}
#t14_18{left:184px;bottom:628px;letter-spacing:-0.1px;}
#t15_18{left:184px;bottom:585px;letter-spacing:-0.09px;}
#t16_18{left:184px;bottom:567px;letter-spacing:-0.09px;}
#t17_18{left:184px;bottom:549px;letter-spacing:-0.08px;}
#t18_18{left:184px;bottom:530px;letter-spacing:-0.08px;word-spacing:-0.42px;}
#t19_18{left:184px;bottom:512px;letter-spacing:-0.1px;}
#t1a_18{left:267px;bottom:520px;letter-spacing:-0.09px;}
#t1b_18{left:184px;bottom:460px;letter-spacing:-0.1px;}
#t1c_18{left:184px;bottom:243px;letter-spacing:-0.08px;}
#t1d_18{left:378px;bottom:619px;letter-spacing:-0.1px;}
#t1e_18{left:378px;bottom:601px;letter-spacing:-0.09px;}
#t1f_18{left:533px;bottom:609px;}
#t1g_18{left:378px;bottom:505px;letter-spacing:-0.09px;}
#t1h_18{left:378px;bottom:487px;letter-spacing:-0.09px;}
#t1i_18{left:444px;bottom:494px;}
#t1j_18{left:569px;bottom:548px;letter-spacing:-0.09px;}
#t1k_18{left:569px;bottom:530px;letter-spacing:-0.09px;}
#t1l_18{left:569px;bottom:456px;letter-spacing:-0.08px;}
#t1m_18{left:569px;bottom:438px;letter-spacing:-0.09px;}
#t1n_18{left:896px;bottom:547px;letter-spacing:-0.09px;}
#t1o_18{left:896px;bottom:529px;letter-spacing:-0.1px;}
#t1p_18{left:984px;bottom:536px;letter-spacing:-0.09px;}
#t1q_18{left:896px;bottom:471px;letter-spacing:-0.13px;}
#t1r_18{left:919px;bottom:479px;}
#t1s_18{left:896px;bottom:453px;letter-spacing:-0.1px;}
#t1t_18{left:896px;bottom:434px;letter-spacing:-0.09px;}
#t1u_18{left:896px;bottom:416px;letter-spacing:-0.1px;}
#t1v_18{left:984px;bottom:424px;letter-spacing:-0.12px;}
#t1w_18{left:1067px;bottom:585px;letter-spacing:-0.1px;}
#t1x_18{left:1067px;bottom:566px;letter-spacing:-0.09px;}
#t1y_18{left:1067px;bottom:548px;letter-spacing:-0.07px;}
#t1z_18{left:1067px;bottom:481px;letter-spacing:-0.09px;}
#t20_18{left:1067px;bottom:462px;letter-spacing:-0.06px;}
#t21_18{left:1067px;bottom:444px;letter-spacing:-0.08px;}
#t22_18{left:1067px;bottom:426px;letter-spacing:-0.1px;}
#t23_18{left:1067px;bottom:407px;letter-spacing:-0.25px;}
#t24_18{left:734px;bottom:699px;letter-spacing:-0.09px;}
#t25_18{left:734px;bottom:680px;letter-spacing:-0.09px;}
#t26_18{left:734px;bottom:662px;letter-spacing:-0.25px;}
#t27_18{left:36px;bottom:778px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t28_18{left:184px;bottom:420px;letter-spacing:-0.09px;}
#t29_18{left:184px;bottom:402px;letter-spacing:-0.11px;}
#t2a_18{left:299px;bottom:410px;letter-spacing:-0.09px;}
#t2b_18{left:184px;bottom:384px;letter-spacing:-0.08px;}
#t2c_18{left:184px;bottom:365px;letter-spacing:-0.1px;}
#t2d_18{left:303px;bottom:373px;}
#t2e_18{left:184px;bottom:347px;letter-spacing:-0.09px;}
#t2f_18{left:184px;bottom:329px;letter-spacing:-0.1px;}
#t2g_18{left:272px;bottom:336px;letter-spacing:-0.13px;}
#t2h_18{left:777px;bottom:383px;letter-spacing:-0.09px;}
#t2i_18{left:777px;bottom:365px;letter-spacing:-0.09px;}
#t2j_18{left:843px;bottom:365px;letter-spacing:-0.25px;}
#t2k_18{left:371px;bottom:693px;letter-spacing:-0.1px;}
#t2l_18{left:371px;bottom:673px;letter-spacing:-0.09px;}
#t2m_18{left:371px;bottom:385px;letter-spacing:-0.1px;}
#t2n_18{left:371px;bottom:364px;letter-spacing:-0.09px;}
#t2o_18{left:623px;bottom:184px;}
#t2p_18{left:633px;bottom:178px;letter-spacing:0.06px;}
#t2q_18{left:631px;bottom:161px;letter-spacing:0.04px;word-spacing:0.02px;}
#t2r_18{left:631px;bottom:144px;letter-spacing:0.04px;word-spacing:0.02px;}
#t2s_18{left:631px;bottom:127px;letter-spacing:0.07px;}
#t2t_18{left:715px;bottom:127px;}
#t2u_18{left:623px;bottom:117px;}
#t2v_18{left:633px;bottom:111px;letter-spacing:0.12px;}
#t2w_18{left:664px;bottom:111px;letter-spacing:0.12px;}
#t2x_18{left:742px;bottom:111px;letter-spacing:0.08px;word-spacing:0.05px;}
#t2y_18{left:896px;bottom:609px;letter-spacing:-0.13px;}
#t2z_18{left:920px;bottom:616px;}
#t30_18{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_18{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_18{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_18{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_18{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_18{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_18{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_18{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_18{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_18{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_18{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sa_18{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sb_18{font-size:14px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_18{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts18" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg18Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg18" style="-webkit-user-select: none;"><object width="1210" height="935" data="18/18.svg" type="image/svg+xml" id="pdf18" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_18" class="t s0_18">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_18" class="t s1_18">® </span>
<span id="t3_18" class="t s0_18">(NCCN </span>
<span id="t4_18" class="t s1_18">® </span>
<span id="t5_18" class="t s0_18">), All rights reserved. NCCN Guidelines </span>
<span id="t6_18" class="t s1_18">® </span>
<span id="t7_18" class="t s0_18">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_18" class="t s2_18">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_18" class="t s2_18">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_18" class="t s3_18">NCCN Guidelines Version 4.2024 </span>
<span id="tb_18" class="t s3_18">Cancer of the Oropharynx (p16-negative) </span>
<span id="tc_18" class="t s4_18">NCCN Guidelines Index </span>
<span id="td_18" class="t s4_18">Table of Contents </span>
<span id="te_18" class="t s4_18">Discussion </span>
<span id="tf_18" class="t s5_18">ORPH-4 </span>
<span id="tg_18" class="t s6_18">k </span>
<span id="th_18" class="t s7_18">Principles of Surgery (SURG-A)</span><span id="ti_18" class="t s8_18">. </span>
<span id="tj_18" class="t s6_18">l </span>
<span id="tk_18" class="t s8_18">Tumors in the base of tongue, posterior pharyngeal wall, and soft palate require </span>
<span id="tl_18" class="t s8_18">consideration of bilateral neck treatment as do tumors of the tonsil invading the </span>
<span id="tm_18" class="t s8_18">tongue base. </span>
<span id="tn_18" class="t s6_18">n </span>
<span id="to_18" class="t s7_18">Principles of Radiation Therapy (ORPH-A)</span><span id="tp_18" class="t s8_18">. </span>
<span id="tq_18" class="t s6_18">o </span>
<span id="tr_18" class="t s7_18">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="ts_18" class="t s8_18">. </span>
<span id="tt_18" class="t s5_18">CLINICAL </span>
<span id="tu_18" class="t s5_18">STAGING </span>
<span id="tv_18" class="t s5_18">TREATMENT OF PRIMARY AND NECK </span>
<span id="tw_18" class="t s5_18">ADJUVANT TREATMENT </span>
<span id="tx_18" class="t s5_18">p16-negative </span>
<span id="ty_18" class="t s5_18">T1–4a,N2–3 </span>
<span id="tz_18" class="t s5_18">Concurrent </span>
<span id="t10_18" class="t s5_18">systemic </span>
<span id="t11_18" class="t s5_18">therapy/RT </span>
<span id="t12_18" class="t s9_18">n,o </span>
<span id="t13_18" class="t s5_18">or </span>
<span id="t14_18" class="t s5_18">or </span>
<span id="t15_18" class="t s5_18">Resection of </span>
<span id="t16_18" class="t s5_18">primary and </span>
<span id="t17_18" class="t s5_18">ipsilateral or </span>
<span id="t18_18" class="t s5_18">bilateral neck </span>
<span id="t19_18" class="t s5_18">dissection </span>
<span id="t1a_18" class="t s9_18">k,l </span>
<span id="t1b_18" class="t s5_18">or </span>
<span id="t1c_18" class="t s5_18">Clinical trials </span>
<span id="t1d_18" class="t s5_18">No adverse </span>
<span id="t1e_18" class="t s5_18">pathologic features </span>
<span id="t1f_18" class="t s9_18">p </span>
<span id="t1g_18" class="t s5_18">Adverse pathologic </span>
<span id="t1h_18" class="t s5_18">features </span>
<span id="t1i_18" class="t s9_18">p </span>
<span id="t1j_18" class="t s5_18">Extranodal extension </span>
<span id="t1k_18" class="t s5_18">and/or positive margin </span>
<span id="t1l_18" class="t s5_18">Other risk </span>
<span id="t1m_18" class="t s5_18">features </span>
<span id="t1n_18" class="t s5_18">Systemic </span>
<span id="t1o_18" class="t s5_18">therapy/RT </span>
<span id="t1p_18" class="t s9_18">n,o </span>
<span id="t1q_18" class="t s5_18">RT </span>
<span id="t1r_18" class="t s9_18">n </span>
<span id="t1s_18" class="t s5_18">or </span>
<span id="t1t_18" class="t s5_18">Systemic </span>
<span id="t1u_18" class="t s5_18">therapy/RT </span>
<span id="t1v_18" class="t s9_18">n,o </span>
<span id="t1w_18" class="t sa_18">Follow-up </span>
<span id="t1x_18" class="t sa_18">(FOLL-A, 1 </span>
<span id="t1y_18" class="t sa_18">of 2) </span>
<span id="t1z_18" class="t s5_18">Recurrent </span>
<span id="t20_18" class="t s5_18">or </span>
<span id="t21_18" class="t s5_18">persistent </span>
<span id="t22_18" class="t s5_18">disease </span>
<span id="t23_18" class="t sa_18">(ADV-3) </span>
<span id="t24_18" class="t s5_18">Recurrent or </span>
<span id="t25_18" class="t s5_18">persistent disease </span>
<span id="t26_18" class="t sa_18">(ADV-3) </span>
<span id="t27_18" class="t s5_18">Base of Tongue/Tonsil/Posterior Pharyngeal Wall/Soft Palate </span>
<span id="t28_18" class="t s5_18">Induction </span>
<span id="t29_18" class="t s5_18">chemotherapy </span>
<span id="t2a_18" class="t sb_18">o,q </span>
<span id="t2b_18" class="t s5_18">(category 3) </span>
<span id="t2c_18" class="t s5_18">followed by RT </span>
<span id="t2d_18" class="t s9_18">n </span>
<span id="t2e_18" class="t s5_18">or systemic </span>
<span id="t2f_18" class="t s5_18">therapy/RT </span>
<span id="t2g_18" class="t s9_18">n,o </span>
<span id="t2h_18" class="t s5_18">Recurrent or persistent </span>
<span id="t2i_18" class="t s5_18">disease </span><span id="t2j_18" class="t sa_18">(ADV-3) </span>
<span id="t2k_18" class="t sa_18">Post Systemic Therapy/RT or RT </span>
<span id="t2l_18" class="t sa_18">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t2m_18" class="t sa_18">Post Systemic Therapy/RT or RT </span>
<span id="t2n_18" class="t sa_18">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t2o_18" class="t s6_18">p </span>
<span id="t2p_18" class="t s8_18">Adverse pathologic features: extranodal extension, positive margins, close </span>
<span id="t2q_18" class="t s8_18">margins, pT3 or pT4 primary, pN2 or pN3 nodal disease, nodal disease in </span>
<span id="t2r_18" class="t s8_18">levels IV or V, perineural invasion, vascular invasion, and lymphatic invasion </span>
<span id="t2s_18" class="t s7_18">(Discussion)</span><span id="t2t_18" class="t s8_18">. </span>
<span id="t2u_18" class="t s6_18">q </span>
<span id="t2v_18" class="t s8_18">See </span><span id="t2w_18" class="t s7_18">Discussion </span><span id="t2x_18" class="t s8_18">on induction chemotherapy. </span>
<span id="t2y_18" class="t s5_18">RT </span>
<span id="t2z_18" class="t s9_18">n </span>
<span id="t30_18" class="t sc_18">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
